RTC
IDXX icon

Riverview Trust Company’s Idexx Laboratories IDXX Stock Holding History

Riverview Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48
Closed -$20.2K – 387
2025
Q1 		$20.2K Hold
48
– – 0.02% 429
2024
Q4 		$19.8K Sell
48
-2
-4% -$877 0.02% 469
2024
Q3 		$25.3K Buy
50
+2
+4% +$972 0.02% 374
2024
Q2 		$23.4K Hold
48
– – 0.02% 376
2024
Q1 		$25.9K Buy
+48
New +$26.2K 0.02% 386
2023
Q3 		– Sell
-28
Closed -$14.1K – 694
2023
Q2 		$14.1K Buy
+28
New +$13.4K 0.01% 576
2022
Q4 		– Sell
-109
Closed -$36K – 789
2022
Q3 		$36K Buy
109
+73
+203% +$26.8K 0.03% 250
2022
Q2 		$13K Sell
36
-13
-27% -$5.3K 0.01% 561
2022
Q1 		$27K Buy
+49
New +$25.8K 0.02% 364

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Riverview Trust Company's IDXX Position: Q2 2025 in Review

Riverview Trust Company sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 48 shares — an estimated $20.2K sold.

Riverview Trust Company first reported a position in IDXX in Q1 2022 and held it in 9 quarters. The position peaked at $36K in Q3 2022. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Riverview Trust Company reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 48 Idexx Laboratories shares in Q2 2025, an estimated $20.2K.
  • Riverview Trust Company first reported a position in Idexx Laboratories in Q1 2022 and held it in 9 quarters.
  • Riverview Trust Company's Idexx Laboratories position peaked at $36K in Q3 2022.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.